Beatty, Alexander http://orcid.org/0000-0002-6054-4064
Singh, Tanu
Tyurina, Yulia Y.
Tyurin, Vladimir A.
Samovich, Svetlana
Nicolas, Emmanuelle
Maslar, Kristen http://orcid.org/0000-0002-9153-3122
Zhou, Yan
Cai, Kathy Q.
Tan, Yinfei
Doll, Sebastian
Conrad, Marcus http://orcid.org/0000-0003-1140-5612
Subramanian, Aravind
Bayır, Hülya http://orcid.org/0000-0003-2361-4120
Kagan, Valerian E. http://orcid.org/0000-0002-7245-1885
Rennefahrt, Ulrike
Peterson, Jeffrey R. http://orcid.org/0000-0002-0604-718X
Funding for this research was provided by:
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-19-1-0481)
Article History
Received: 31 July 2020
Accepted: 11 March 2021
First Online: 14 April 2021
Competing interests
: Ulrike Rennefahrt is a former employee of Metanomics Health, GmbH. Marcus Conrad is an inventor on patents for some of the compounds described herein, and shareholder of ROSCUE Therapeutics GmbH. The remaining authors declare no competing interests.